A fifth Covid vaccination has been given regulatory approval in the UK.
Nuvaxovid, developed by Novavax, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) after safety, quality and effectiveness tests.
The next step will see it considered for use in the Covid-19 vaccination programme, health secretary Sajid Javid said today (Thursday, February 3).